The Rheumatoid Shoulder: Current Surgical Treatments by Aydin, Nuri et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 9
The Rheumatoid Shoulder: Current Surgical Treatments
Nuri Aydin, Lercan Aslan, Janne Lehtinen and
Vedat Hamuryudan
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.71452
Abstract
Background: Rheumatoid arthritis (RA) is an inflammatory disease resulting in pain and
decreased functional outcome. Even though most of large joints are widely discussed in
literature, shoulder’s surgical treatment options, indications and superiorities to each
other were not compared entirely.
Materials and methods: Treatment options, such as synovectomy and bursectomy, resec-
tion interposition arthroplasty (RIAP), hemiarthroplasty, humeral resurfacing arthroplasty,
anatomical total shoulder arthroplasty (TSA) and reverse shoulder arthroplasty (RSA) are
examined and compared according to timing, advantages and disadvantages.
Results: Age is the primary criteria for decision making. Young-aged patients demand
high functionality, alas need for revision in the future must be planned. First step is
preservation of bone stock as much as possible. For young patient, disabling pain can be
candidate for synovectomy and bursectomy or RIAP and also for hemiarthroplasty. As
age progresses, priorities change towards rotator cuff status and glenoid bone stock.
Conclusions: Age, functional demand, rotator cuff status, adequacy of glenoid bone stock
and future planning for possible complications are defined as major criteria for optimal
treatment. RA patients will require systemic evaluations with help of rheumatologists.
Patient, rheumatologist and orthopaedist should discuss the possible surgical intervention
together to achieve high quality of life.
Keywords: rheumatoid arthritis, rheumatoid shoulder, surgical techniques, arthroplasty,
synovectomy
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
1.1. Epidemiology
Rheumatoid arthritis (RA) is an inflammatory process that may lead to disability as a result of
joint destruction. The prevalence of RA is less than 1% in the general population and women
are affected three times more as men but this sex difference weakens in the elderly. The onset of
the disease is mostly during the fourth and fifth decades. Family studies have indicated a
genetic predisposition with an increased frequency of the disease among the first-degree
relatives and twins [1]. An association with human leukocyte antigen (HLA)-DR4 was shown
in 70% of the Caucasian and Japanese patients compared to 28% of the controls [2, 3]. The
discovery of rheumatoid factor (RF) in 1940s, led to hopes that blood tests could provide gold
standard biomarkers in the recognition of the disease [4]. Approximately 70% of RA patients
have a positive RF or anti-cyclic citrullinated peptide antibodies (ACPA) along with elevated
erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) [5–7].
New Genome-Wide Association Studies (GWAS) showed a total of 101 single nucleotide poly-
morphisms (SNPs) associated with immune dysregulation and inflammation. T-reg cells seem
to be defective in RA patients [8]. Also, GWAS studies identified potential therapeutic targets.
One study showed RA risk in a special pathway, which is called kappa B signaling pathway
(NF-kB). Engagement of CD40 is one of the ways this pathway can be triggered and can be
targeted for treatment [9]. Another new treatment method focuses on the Janus kinase (JAK)
pathway [10]. This pathway is the main signaling mechanism in response to many cytokines
involved in RA, including IL-6 [11]. Human leukocyte antigen (HLA) class II locus is associated
less with the risk of developing ACPA andmore ACPA-positivity to have RA [12]. In the recent
years, environmental factors like smoking and pulmonary inflammation was shown to be
associated with the emergence of the disease [13]. By using new methods that integrate genetic
data with biochemical pathways and cell types involved in the disease, real progress has been
made about RA pathophysiology like where and when immune tolerance is broken, which
results in synovial inflammation and bone destruction [14]. Environmental factors needs to be
recognized and their role in breaking RA tolerance should be investigated further [15].
1.2. Diagnosis
Autoimmunity and the overall systemic and articular inflammatory load drive the destructive
phase of the disease, which can be detected by conventional radiography or other imaging
techniques. But the joint destruction is rarely visible in the early stages of the disease [16]. In the
last decade, the use of disease-modifying antirheumatic drugs (DMARDs), particularly metho-
trexate (MTX) and the availability of new biologic agents have dramatically enhanced the success
of RA management [17, 18]. It was shown that early therapeutic intervention improves clinical
and radiological outcomes [19]. Up to now it was not possible to effectively investigate the
efficacy of early interventions in terms of their ability to prevent later stage RA, since there are
not enough data or accepted criteria to group such patients with early disease. In 1987, American
College of Rheumatology (ACR) published the criteria for diagnosis [20]. The criteria required
four or more of the following: (a) morning stiffness for at least 1 hour for at least 6 weeks,
Advances in Shoulder Surgery170
(b) soft-tissue swelling of three or more joints at least 6 weeks, (c) swelling of the proximal
interphalangeal, metacarpophalangeal or wrist joints for at least 6 weeks, (d) symmetric joint
swelling for at least 6 weeks, (e) rheumatoid nodules, (f) RF positive blood test and (g) radio-
graphic changes like erosions or osteopenia in hand and wrist joints. These criteria are
widely accepted for the diagnosis, but have a limitation in that they were derived for trying to
discriminate patients with RA from those with a combination of other rheumatologic diagnosis.
Early identification in the patients was not possible with the use of these criteria. In 2010, a joint
working group of the ACR and the European League Against Rheumatism (EULAR) was
formed to develop a new classification for RA. The newly developed criteria’s were designed
also as a referral tool for primary care physicians. The number of joints involved, small or large
joints, serology (RF, negative or positive ACPA, CRP, ESR) and the duration of symptoms are
noted. Every possibility has different points. If the patient has more than six points, the patient
has a definitive RA [17] (Table 1).
Who should be tested?
Target population
1. Have at least one joint with definite clinical synovitis (swelling)
2. With the synovitis not better explained by another disease
Classification criteria for Rheumatoid Arthritis*, **
A. Joint Involvement Score
1 Large Joint 0
2–10. Large joints 1
1–3 Small Joints (with/without involvement of large joints) 2
4–10 Small joints (with/without involvement of large joints) 3
>10 Joints (at least one small joint) 5
B. Serology† Score
Negative rheumatoid factor and negative anti-citrullinated protein antibody 0
Low-positive rheumatoid factor or low-positive anti-citrullinated protein antibody 2
High-positive rheumatoid factor or high-positive anti-citrullinated protein antibody 3
C. Acute-phase reactants† Score
Normal C-reactive protein and normal sedimentation rate 0
Abnormal C-reactive protein or abnormal sedimentation rate 1
D. Duration of symptoms Score
<6 weeks 0
≥6 weeks 1
*Score-based algorithm: add score of categories A–D.
**A score of ≥6/10 is needed for classification of a patient as having definite rheumatoid arthritis.
†At least one test is needed for classification.
Table 1. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for
rheumatoid arthritis [17].
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Joint status of the RA patients was needed to be evaluated after biological agent administration
for remission of the disease. Joint destruction pattern under biologic agents were widely
discussed. Fukae et al. [21] had shown under X-ray imaging of fingers, Yoshimi et al. [22] by
ultrasound and Suzuki et al. [23] evaluated the synovitis of the hand by the help of MRI.
Yonemoto et al. had chosen the 18F-fluorodeoxyglucose positron emission tomography for
the evaluation of the destruction. They shared the results of the previous studies of the authors
mentioned that even though clinical status of the patient may improve, the synovitis thus
destruction was only slowed [24].
In multiple-joint involvement type of the disease, shoulder joint is commonly involved. But it is
rarely affected in monoarticular fashion. The clinical presentation may be different in every
patient. It can be symmetrical, episodic and silent between periods of remission. The clinical
presentation may start with musculoskeletal pain, fever, fatigue or malaise. At the same time,
other joints may present with erythema, pain and stiffness after inactivity. In the early stages of
this disease, inflammatory changes of the subacromial soft tissue like bursitis, tenosynovitis of
the long head of the biceps tendon resulting in defects of the rotator cuff. Rotator cuff is affected
both by the synovial proliferations of the glenohumeral joint and the synovitis of the subacromial
bursa. The starting point of the destruction of the rotator cuff is often a partial defect of the
supraspinatus tendon at the attachment side to the humeral head. The intraoperative rate of this
pathology lies between 30 and 90% of the cases, intratendinous defects between 20 and 40%,
partial defects and simply thinning-out is found 80% of the cases [25]. Glenohumeral joint, at the
beginning, is not really painful because of the large intracapsular space. The first cartilage bone
change starts from humeral head that leads to deformation of the head [26]. Pain originates from
the capsule, that is sensitive to stretch and distension. The increase in the synovial fluid and
hypertrophy of the synovium leads to increase in intra-articular pressure. To overcome this
condition, the shoulder is positioned in slight flexion and internal rotation. By this way, the
capsular volume is increased [1].
The initial presentation around the shoulder is pain and loss of motion. With the progression of
the disease, loss of elevation and external rotation are noted. The initial presentation of the
disease can be subacromial bursitis with giant rice bodies in some patients, which may mimic
impingement syndrome [27]. Villous synovial hypertrophic tissues (pannus) may result in
crepitation and pain during motion. At the inflammatory phase, the patient experiences a
constant aching even at rest and being worst at night. In rare cases, scapulothoracic bursa can
become inflamed and painful [28]. It should be kept in mind that, in rheumatoid shoulder, the
affected joint is not only the GH joint, also acromioclavicular joint (AC) is affected. It was found
that in RA patients, AC joint is affected more frequently than the GH joint, but in half of the
patients both joints are involved. This should be remembered when treating painful rheuma-
toid shoulder [29].
The shoulder joint is affected in approximately 60% of hospitalized patients with RA [30, 31]. The
pain around the shoulder area was reported in 50% of newly diagnosed RA patients [32]. The
degree of dysfunction of the shoulder is related to the severity of the rheumatoid disease [33]. It
was reported that 48% of RA patients developed glenohumeral erosive changes and 13% devel-
oped pathologic joint space narrowing. Plain radiographs of the rheumatoid shoulder are the
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primary diagnostic tools for evaluating the glenohumeral joint (GH). According to prospective
study of Kojima et al., RA patients were evaluated for their range of motion of large joints and
the effect on the daily activities. Disability of daily activities like dressing, arising, eating, walking
and personal hygiene was strongly correlated with shoulder abduction limitations [34].
Medial migration and remodeling of the humeral head with medialization of the GH joint due
to bony erosion are common radiographic findings in RA [35]. The rotator cuff insufficiency
provokes superior migration of the humeral head with medialization.
Larsen defined the widely used radiographic classification of rheumatoid shoulder in 1977.
According to this classification, in stage 0: there is no sign on plain X-ray; stage I: arthritic
changes with osteopenia and periarticular tissue swelling; stage II: narrowing of the joint
space and erosions; stage III: cysts, increased loss of joint space, superior migration of the
humeral head because of rotator cuff insufficiency; stage IV: loss of contours of the articular
surface, flattening of the humeral head, medialization of the glenoid; and stage V: severe
bony deformation with loss of joint contours and superior migration of the humeral head
[36]. Ultrasonography (USG) is also a helpful tool in the shoulder joint. Thus radiography
gives limited information about the soft tissue changes, USG could show possible patholo-
gies of the periarticular tissues, especially at the beginning of the disease. It is easy to detect
inflammatory changes in the subacromial space like bursitis, tendinitis of the long head of
the biceps tendon and rotator cuff tears [37]. Magnetic resonance imaging (MRI) and
computerized tomography (CT) are not needed for classification of the disease. But they
are useful to answer some special questions like tumoral infiltration, fatty infiltration of
the muscles and preoperative planning of shoulder arthroplasty [38, 39]. Evaluation of
the degree of periarticular soft tissues is important when deciding on the best treatment
strategy [33].
Amundsen et al. investigated the arthroplasty mortality rates for various aetiologies. A total of
214 RA patients were included and on the postoperative 90th day and first year, significantly
higher mortality rate was encountered. Even though the highest mortality rate was encoun-
tered for fracture patients, RA patients’ increased mortality rate must be kept in mind for
surgical intervention [40].
Best treatment strategy takes into account the overall condition of the patient and the involve-
ment of other joints. There might be need for lower limb surgery and the use of walking aids.
Sometimes the involvement of other, distal joints in the upper arm affects the timing of shoulder
surgery/reconstruction.
2. Current surgical treatments
2.1. Synovectomy and bursectomy
In RA, synovium produces chemokines and cytokines, which are responsible for pain and
swelling of the joint and later for the articular destruction [41]. Synovectomy is a treatment
method aimed for pain relief and treatment of joint swelling before bony erosions occur [42].
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Indication of synovectomy may be considered when appropriate medical treatment fails after
a period of 6–12 months [41]. Open synovectomy and bursectomy was first described by Pahle
in 1973 [43]. Schmidt et al. accomplished arthroscopic approach for synovectomy in 1994 [44].
Although the clinical results are not significantly different between open and arthroscopic
synovectomy, due to the immunosuppression resulted by medical treatments and disease
itself, arthroscopic approach is mostly preferred. Also short hospital stay and lower risk of
shoulder motion restriction are the additional advantages of arthroscopic approach [42].
The results of this treatment method for rheumatoid shoulder are widely discussed in the
literature [42–46].
Ossyssek et al. reported two-staged synovectomy in rheumatoid knee. In the first stage,
synovectomy was performed and the prominent area of synovitis was marked. In the second
look, previously marked synovium area was collected and investigated by immunofluores-
cence. After the first stage, 94% of the patients’ pain was relieved and was linked to the results
of immunofluorescence which has shown reduced sensory innervations [47].
In Petersson’s open synovectomy series, 21 patients who had gradually increased pain and
restriction of motion despite medical management and hydrocortisone injections, were
included. Three of 21 patients had advanced arthritic changes at the time of surgery and was
not excluded. A mean follow-up of 4 years revealed that if joint cartilage is well preserved, the
efficacy of synovectomy and bursectomy increases, thus the functional outcome [45]. Also
Petersson stated that in spite of Pahle et al.’s report for synovectomy’s favorable outcomes in
advanced arthritis, synovectomized 2 out of 3 advanced arthritic patients were dissatisfied and
required arthroplasty [45, 48].
On contrary, Kanbe et al. performed arthroscopic synovectomy and capsular release to
54 patients and reported that excellent outcomes can be achieved even if the radiological changes
have been occurred. These patients’ had shorter disease duration, younger age and lower
prednisolone usage. Based on these prognostic factors, a patient even with bone and cartilage
destruction might have a good clinical outcome after synovectomy. They also suggested
that medical treatment alone will not suffice to stop the progression of inflammation and
synovectomy should be performed to obtain improved quality of life before rotator cuff tear
occurs [42].
As for late stage rheumatoid shoulders, Wakitani et al. accepted success of synovectomy for
pain relief, but pointed out shoulder arthroplasty had better functional outcomes in addition
to pain relief, which limited the indications of synovectomy for early stage rheumatoid shoul-
ders [49].
In conclusion, arthroscopic synovectomy and bursectomy is the first line of surgical treatment
not a decisive solution in early staged rheumatoid shoulder. But this treatment is mostly
symptomatic because of the inability to stop the progression of erosions in the joint. This
procedure can delay the need for arthroplasty for the patients approximately 4 years, but as
the disease progresses, the need for arthroplasty will be evident. In Table 2, the literature is
summarized according to functional status and complications. When considering the surgical
outcomes, the limitations of this surgery should be widely discussed with the patients [50].
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Publications n A/O Follow-up
(mean) (months)
Age (mean)
(years)
Pain
relief*/**
Result Pre-op
score
Post-op score Conversion
to
arthroplasty
Conclusion
Kanbe et al.
[41]
7 A 13 (range 13) 62 (range 49–68) N/E Decreased CRP levels,
increased efficacy of
RA medications
N/A N/A — Combination of medical
treatment and
synovectomy, slows the
progression of arthritis
Smith et al.
[46]
16 A 66 (range 12–120) 49 (range 28–71) 13/16 15 increase in ER
34 increase in FF
(statistically
significant)
ASES: N/A
SST: N/A
ASES: 60
(range 47–67)
SST: 8
(range 6–11)
1 Good functional results
and pain relief in rotator
cuff intact shoulders
Kanbe et al.
[42]
54 A 60  40.92 53.3 (range N/A) N/E 30 increase ER
48 increase FF
JOA:
36.65  7.66
JOA:
84.61  12.74
— Good functional results
can be obtained before the
tear of
rotator cuff
Pahle [48] 54 O 64 (range N/A) N/A 6/54 %10 increased
shoulder functions
N/A N/A 6 Good functional results in
early stages
Petersson
[45]
13 O 48 (range N/A) 60 (range 31–73) 5/12 29 increase ER
44 increase FF
N/A Pain Score:
1.3 (range 1–3)
2 Good functional results in
early stages
Abbreviations: CRP, C-reactive protein; RA, rheumatoid arthritis; ER, external rotation; FF, forward flexion; ASES. American Shoulder and Elbow Surgeons Score; SST,
Simple Shoulder Test; JOA, Japanese Orthopedic Association Score; N/E, not evaluated.
*Satisfied patients with pain-free or mild pain.
**Total number of participated patients.
Table 2. Summary of previous publications about synovectomy and bursectomy in RA patients.
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2.2. Resection and interposition arthroplasty
When the glenohumeral joint destruction occurs and patient suffers from severe pain, at this
point arthroplasty becomes the treatment of choice. But first generation of shoulder
arthroplasties had resulted with high rate of loosening, thus patients’ morbidity increased
[51]. Till the advancement of shoulder prosthesis, resection and interposition arthroplasty was
preferred by several authors because of the preservation of glenoid and humeral head bone
stock and enabling further revisions [52]. This procedure is mostly selected for high life
expectant patients with advanced glenohumeral arthritis suffering from severe pain [51].
Principle of this procedure, damaged cartilages of glenoid and humeral head are resected, radical
open synovectomy is performed and soft tissues are interpositioned between articulations,
ultimately a new joint is formed [52]. Historically, porcine bladder was used as the soft tissue
[53] and in time skin, fascia, tendon, muscle [54] and eventually dura mater [52] were used as
membranes for interposition. Porcine bladder was mostly used in temporomandibular joint
interposition surgeries and dura mater was used in elbow, temporomandibular joint interposi-
tion surgeries [55–57].
Milbrink et al. advocated functional outcome of resection interposition arthroplasty was even
better than prosthetic arthroplasty. Although the operation fails in time, as the remaining bone
stock was well preserved, conversion to arthroplasty or arthrodesis was still possible [52]. But
the advancements in shoulder arthroplasty had nullified this statement [51].
Fink et al. observed 53 shoulders for a mean follow-up of 8.2 years. They stated that after
10 years, the functional outcome of resection interposition arthroplasty decreases dramatically.
This phenomenon is explained by the medialization of joint’s center of rotation because of
progressive resorption of humeral head [51]. As Strauss et al. stated, the medialization of joint
center by resection interposition surgery deltoid abduction lever arm decreases by 35%
resulting in poor functional outcomes [58]. They supported indication for resection interposi-
tion arthroplasty for the group of very young-aged patients because of preservation of bone
stock and delay the need for prosthesis [51]. But the pain relief is controversial, maximum
active abduction is mostly limited to 60–80 and moderate weakness can persist even though
the rotator cuff was sutured [59].
In conclusion; with the advancement of shoulder prosthesis, the indication for resection inter-
position arthroplasty is declined in time, but theoretically for the young-aged patients with
advanced glenohumeral arthritis may be the candidates for resection and interposition arthro-
plasty due to the preservation of glenohumeral joint and thus delaying the need of prosthetic
reconstruction, but practically we saw that newest shoulder resection and interposition sur-
gery literature is from year of 2001, that is because surgeons began to prefer arthroplasty for
arthritic patients [50]. The postoperative functional status, complications and revision to
arthroplasty are summarized in Table 3.
2.3. Resurfacing arthoplasty
The idea for resurfacing arthroplasty was to correct deformed humeral head with minimal bone
loss. The need for this idea was because of reported high incidence of glenoid loosening with
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Publications n Age
(mean)
Follow-up
(mean)
Satisfaction Pre-op
score
Post-op
score
Improvement
in FF
Improvement
in ER
Complication Conclusion
Milbrink
et al. [52]
13 N/A 6 months
(prognostic)
%100 N/A N/A 48 N/A None Resection interposition arthroplasty’s
results are even superior to some
endoprosthetic reconstructions and also
enable adequate bone stock for total
shoulder arthroplasty if revision is
needed.
Fink et al.
[51]
42 47.9
(range
18–68)
98.4 months
(range 42–
210)
Constant:
N/A
SAS: N/A
Constant:
42.33
SAS:
26.43
27.5 2.39 1 (rotator cuff
tear, painful
shoulder)
Even though functions after resection
interposition arthroplasty improve in
the long-term deterioration of the scores
was witnessed. Young-aged patients
may be logical candidates for reserving
bone stock for total shoulder
arthroplasty revision in the future
Abbreviations: ER, external rotation; FF, forward flexion; SAS, Society of American Shoulder and Elbow Surgeons Basic Shoulder Evaluation Form.
Table 3. Summary of previous publications about resection and interposition arthroplasty in RA patients.
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unpredicted bony erosion during revision surgery after stemmed arthroplasty. Also the applica-
tion of stems with cement intraoperatively might result in cracking osteopenic humerus shaft of
rheumatoid patients. Postoperatively as intramedullary stem leads to stress rise at the tip of the
prosthesis, RA patients are prone to fractures around the stem of prosthesis and are hard to
manage [60, 61].
The advantages of resurfacing arthroplasty are short operative time, low risk of intraoperative or
postoperative periprosthetic fractures andminimal bone resection. Thedisadvantages aredifficulty
in correction of the anatomical fitting in caseswith extremely deformed humeral head [62, 63].
Rydholm and Sjögren published their mid-term clinical results in 72 rheumatoid shoulders
with 94% pain relief and 82% improved mobility. Patients were followed-up for 4.2 years and
were evaluated radiographically and functionally. About 25% of patients had shown loosening
of the cup. But interestingly, no relationship was found between the position of the cup and the
clinical outcomes of the patients. Neither superior migration of the humeral head in 38% nor
central attrition of the glenoid in 22% showed any relation to gain of mobility, pain nor
functional scores [64]. A counter-argument against resurfacing arthroplasty is that progressive
erosion of the glenoid will make future arthroplasty more difficult and the need for total
shoulder arthroplasty (TSA) will be earlier and harder as would be advocated for
hemiarthroplasty. But in this series of patients they found no relation between the central
glenoid erosion and the patient clinical outcomes [64].
Ålund et al. published their 2–6 year results in 33 RA patients. Their findings also showed no
correlation between clinical results and radiographic superior migration of the humeral head
with or without glenoid erosion. About 25% of the patients showed radiographic signs of cup
loosening. They found good pain relief in 27 of the shoulders. The remaining six shoulders
were still painful at follow-up [65].
Levy and Copeland published their results with the Copeland Mark-2 Prosthesis with 5–10
year results. In this series, 41 patients out of 94 were RA. There was no difference between the
RA and primary osteoarthritis patients in terms of functional clinical scores. Only one RA
patient revised to TSA due to loosening. About 93.9% of the patients were satisfied by this
procedure [61, 66]. RA patients had better functional results when compared to groups of
rotator cuff tear and instability arthropathy.
Fink et al. published the results of 45 RA patients. The patients were divided into three groups
according to the cuff pathology: intact, partial tear and total tear. In all three groups, there was
significant increase of the functional scores. But the least increase was observed in total rotator
cuff tear group. They experienced no complications like component loosening or change in the
cup position. Therefore, cup arthroplasty was stated as a good alternative to other arthroplasty
solutions in rheumatic patients [67].
Thomas et al. reported their outcome of 56 patients followed-up for at least 2 years. A total of
26 out of 56 patients were RA patients. They reported good clinical outcomes in RA patients
when compared to the other indications. The survival analysis showed no variance from
acceptable standards for shoulder arthroplasty during the study period. The preservation of
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the bone stock for a possible revision surgery and enabling to restore the individual height,
version and offset are important advantages for surface arthroplasty [68].
Fuerst et al. published their results of 35 shoulders for a follow-up of at least 5 years in patients
with RA. Three revisions were mentioned. These were due to need of conversion to a larger
implant, glenoid erosion and loosening. Over the 5-year follow-up, superior migration of the
humeral head encountered in 63% and the glenoid depth increased in 31%. Clinically, no
difference between the patients with massive rotator cuff tear and smaller tear or no tear was
found. Also they suggested magnetic resonance imaging prior to surgery, not only to evaluate
soft tissues like rotator cuff, but also to detect the quality of bone, cysts, necrotic areas and
other defects of the humeral head [69].
Although most of the results of RA patients with resurfacing arthroplasty are good in the
literature given above, Mansat et al. reported worst results in RA patients. In his group of
mixed patients, four rheumatoid shoulders gave worst results among them. And concluded
that, the resurfacing arthroplasty does not resolve the problem of long-term results of
hemiarthroplasty, even it mimics the normal anatomy [70].
Available data on the long-term survival of shoulder arthroplasty is limited. Because of high
functional demands of the younger patients; prosthesis may result in a limited life span and
the need for a revision surgery during their lifetime is probable [50]. Recently, Levy et al.
published their minimum 10 year results of surface replacement arthroplasty in patients
younger than 50 years. This is the longest follow-up result of young-aged RA patients’ series.
Twenty of 49 patients have RA and 4 of 10 revisions were performed in RA patients. The
superior migration of the humeral head was more prevalent in these patients. The revisions
were done due to rotator cuff failure and loosening at 8–14 years after surgery [71]. They found
decreased pain, high satisfaction, good percentage of back to work and sporting activities. As
of our own clinical experience and literature review had shown, resurfacing arthroplasty is
more demanding for the surgeon, with its advantages of minimal resection and functional
outcomes in rotator cuff intact patients, making it a favorable choice.
2.4. Hemiarthroplasty
The first hemiarthroplasty series were published by Neer. They reconstructed three and four
part humerus proximal fractures and took the attention to good functional outcomes [72]. In
the following years, hemiarthroplasty was begun to be preferred for osteoarthritis, RA, cuff
tear arthropathies and fracture sequelae (Figure 1). But superior migration (Figure 2) due to
cuff tear arthropathies led to diminished functions which had shown that hemiarthroplasty
was not the optimal solution for cuff tear arthropathies, thus reverse shoulder arthroplasty
(RSA) was designed [73].
Still there is no consensus on preference of hemiarthroplasty or TSA especially in the cases of
young-aged rheumatoid patients. The main complication of hemiarthroplasty is glenoid ero-
sion which results in medialization of the joint which was seen in 98% of the patients in a study
by Sperling et al. with a mean follow-up of 11.3 years [74], but the risk of glenoidal component
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loosening in TSA and decreased glenoidal bone stock is another concern for the indication for
young-aged patients. Thus, hemiarthroplasty is widely accepted for patients with intact rota-
tor cuff and minimal glenoid erosion [73].
As for RA, indications of arthroplasty are glenohumeral joint destruction with severe pain and
restriction of movements [75]. But this must be kept in mind that, the RA in shoulder differs
from osteoarthritic patients in many ways, such as glenoid is osteopenic, rotator cuff is torn or
thinned and internal rotation is increased due to medial side of glenoid is eroded rather than
posterior as seen in osteoarthritis [75]. Smith et al. described the changes and effect on func-
tional outcomes of arthroplasty performed on rheumatoid shoulders. They mentioned that TSA
was mostly preferred in their practice, because of the prevention of medial erosion of glenoid by
resurfacing and better comfort. Although the advantages of TSA seemed to be better, due to
mentioned changes in glenoid might cause an obstacle for insertion of glenoid component,
thus hemiarthroplasty might be performed which had a similar functional outcome and
pain relief. Also they supported the cementation of humeral component in Sneppen et al.’s
Figure 1. Hemiarthroplasty surgery to a defective glenoid. (A) Preoperative AP plain radiography. (B) Preoperative axial
CT scan. (C) Preoperative coronal CT scan. (D) Early postoperative AP plain radiography.
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TSA series performed on rheumatoid arthritic shoulders. Because the press-fit technique had
shown 40% (5 in 12 patients) loosening, in comparison to cemented humeral components had
shown none (0 in 50 patients) [76, 77].
Because of rotator cuff insufficiency to overwhelm superior migration of the prosthesis, Rozing
et al. conducted a study of rotator cuff repair for shoulder arthroplasty in 1998 including
40 patients (11 were hemiarthroplasty). The follow-up was ranging from 2 to 13 years. They
stated that rotator cuff repair was effective because proximal migration was seen in only 6 of 40
patients. For the surgical technique, if rotator cuff repair is planned, posterosuperior incision
should be preferred because the osteotomization of the posterior acromion was not restricting
the postoperative rehabilitation in contrast to superior approach which requires an osteotomy
including large portion of acromion [75].
Cofield et al.’s study of hemiarthroplasty included 32 rheumatoid shoulders and 35 osteoarthritis
shoulders and followed up for 9.3 years. They stated that pain relief was achieved in 78% of the
patients, external rotation and forward flexion range increased by 26 and 24, respectively.
Although the functional results seemed to be satisfying, the patients’ self-evaluation had shown
that 49% of the patients were satisfied. About 12% of the patients required a revision to TSA
because of intractable pain of glenoid arthritis and postoperative pain relief evaluations were
satisfying. They supported the indication of hemiarthroplasty in inadequate glenoid bone stock
which cannot bear an implant and young aged or active life expectant patients [78, 79].
Sperling et al. compared the hemiarthroplasty and TSA patients below 50 years of age between
the years of 1976 and 1985. Hemiarthroplasty was performed in 74 shoulders, TSA was
performed in 34 shoulders. The radiolucent line adjacent to TSA was 53% for humeral, 59% for
Figure 2. Plain radiography of hemiarthroplasty superior migration.
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glenoid component in spite of 24% which was seen in humeral component of hemiarthroplasty.
In contrary, prosthesis survival analysis revealed at 10 year of follow-up, revision rates of
hemiarthroplasties were increased significantly (17% for hemiarthroplasties, 3% for TSA). Pain
and functional outcome comparison revealed no significant results [80].
In contrary, Collins et al. published a prospective multi-centered study for the comparison of
arthroplasties in RA patients. They stated the hemiarthroplasty indication as young aged, high
activity level anticipated, osteopenic, rotator cuff tear already present, extensive poorly con-
trolled systemic disease. A total of 61 shoulder arthroplasties were included (36 hemiar-
throplasty, 25 TSA) and followed up for 38 months for hemiarthroplasty, 39 months for TSA.
The results of functional scores and pain assessments had shown a slight advantage for TSA,
but patient selection criteria were worse for hemiarthroplasty. The choice for TSA was advised
for the patients with intact or reparable rotator cuff and adequate glenoid bone stock. Because
even the patients’ condition was worse for selection of hemiarthroplasty, functional outcome
and pain relief were increased when compared to preoperative status. Also another concern
for better functional outcome and pain relief criteria was stated as the glenohumeral alignment
which could be achieved better in TSA [81].
Sperling et al.’s 195 TSA and 108 hemiarthroplasty included with 11.3 year follow-up is the
largest patient population. Their comparison of hemiarthroplasty and TSA revealed important
factors for decision. For hemiarthroplasty and TSA, the results for pain relief and functional
outcome were significantly improved. But if the results were evaluated for rotator cuff intact or
reparable and rotator cuff torn patients separately, the rotator cuff intact patients’ survival of
prosthesis, pain relief, functional outcome results were superior to hemiarthroplasty. But for
the rotator cuff deficient shoulders, the results remained the same. As for the main complica-
tion of the prosthesis choice, TSA’s glenoid loosening rates were lower than hemiarthroplasty’s
painful glenoid arthritis [73].
Rees et al. investigated theprimary shoulder hemiarthroplasties forosteoarthritis andRA,but they
subgrouped RA so that the results were clear. Thirty-one patients were evaluated with Oxford
Shoulder Score and transition and satisfaction questions. As for Oxford Shoulder Scores, a statis-
tically significant improvementwas seen, but for the patient satisfaction test the results had shown
that 33.3% of the RApatients wereworse or the same and 29.6%were not pleased [82].
Rozing et al. conducted a study to describe the prognostic factors in arthroplasty for rheumatoid
shoulders. They included 66 TSA and 75 hemiarthroplasty. They stated that hemiarthroplasty
was affected by the preoperative acromioclavicular joint arthrosis and medial migration. But as
for the rotator cuff repair status, proximal migration progression hemiarthroplasty’s Hospital for
Special Surgery clinical score were not affected as much as TSA. Also they stated that 11 patients
who had both hemiarthroplasty and TSA, in their 2nd year follow-up score functional results
had shown no significant difference. They concluded that in the patients with poor glenoid bone
stock and moderate or lower quality rotator cuff repair, hemiarthroplasty was a good treatment
choice [83].
Etiology-based evaluation study by Gadea et al. for hemiarthroplasty resulted with improved
Constant-Murley score and 100% survival of prosthesis [73]. Although this study had a minimum
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Publication N Age
(mean)
Follow-
up
Satisfaction Pre-
op
score
Post-
op
score
Improvement
in ER
Improvement
in FF
Complication Conclusion
Cofield
et al. [78]
32 N/A 9.3 %49 N/A N/A 26 24 N/A Patients with inadequate glenoid bone stock or
high-level activity expectancy might be proper
candidates for hemiarthroplasty
Watson
et al. [79]
4 71 (range
70–73)
5.9
(range
2.5–10)
%100 HSS:
13
HSS:
41.75
25 30 None Bipolar spacer prosthesis might be a good surgical
option for the treatment of advanced
glenohumeral arthritis, but the eventually
encountered loss of low-friction properties of the
sleeve might restrict joint movements.
Sperling
et al. [80]
28 39 (range
19–50
11.7 %66 VAS:
4.6
VAS:
2.4
24 44 N/A Shoulder arthroplasty provides long-term pain
relief and motion improvement, but in young-
aged patients (<50) care should be taken to assess
the appropriate choice due to low survival of
prosthesis.
Collins
et al. [81]
36 58 (range
30–84)
3.1
(range
2–6)
N/A N/A N/A 15 N/A N/A By hemiarthroplasty, pain relief and improved
range of motion are expected when sufficient
glenoidal and humeral bone stock are present
Sperling
et al. [74]
95 54 (range
21–77)
12.1 N/A Pain
score:
4.8
Pain
score:
2.4
18 32 10 (8 glenoid
erosion, 2
loosening)
Shoulder arthroplasty in rheumatoid arthritis
relieves pain and improves shoulder joint range of
motion, but with the presence of intact rotator
cuff, total shoulder arthroplasty’s results had
shown superiority
Rees et al.
[82]
31 63.5  11.9 4.37
(range
3–8)
%70.4 OSS:
13.7
OSS:
28
N/A N/A N/A Rheumatoid arthritis patients less likely satisfied
with their hemiarthroplasty operation. This fact
may be rectified by their systemic pathology
where the joint pain improved but bodily and limb
function did not.
Abbreviations: ER, external rotation; FF, forward flexion; OSS, Oxford Shoulder Score; HSS, Hospital for Special Surgery Score; VAS, Visual Analogue Scale; N/A, not
available.
Table 4. Summary of previous publications comparing hemiarthroplasty and total shoulder arthroplasty in RA patients.
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8 year follow-up, Sperling et al.’s study for survival of prosthesis wasmore dependable because of
its large numbers but as the survival of hemiarthroplasty decreased, after 20th year, it seized to
deteriorate and the lines of hemiarthroplasty and TSA intersected [80]. Thus, they concluded that
hemiarthroplastywas a better treatment option for the young patients (<50 years of age) [73].
In conclusion, hemiarthroplasty provides a painless shoulder with good functional outcomes.
But the literature about comparison of TSA and hemiarthroplasty confirmed that its survival
rate is inferior to TSA. Glenoid bone stock preservation which is enabling future revision
surgeries, good functional outcomes and survival of prosthesis according to Gadea et al. [73]
minimum 8 year and even same survival rate as TSA in long-term as supported by Sperling
et al. [74] are in favor for young RA patients, but the conflict of optimal treatment between the
use of TSA and hemiarthroplasty in recent literature, mostly limit the indication to elderly
patients with insufficient glenoid bone stock and rotator cuff deficient patients [50]. The
literature comparing hemiarthroplasty and TSA are summarized in Table 4.
2.5. The ream and run technique
The glenoid component complications of the TSA created concerns about the indications for
young-aged active patients [80, 84]. The Ream and Run technique, first described by Clinton
et al., is a form of hemiarthroplasty with the reaming of the glenoid. This technique is also
called non-prosthetic reconstruction of the glenoid [85, 86]. Reamed glenoidal surface was
examined on canine model and demonstrated that the reamed glenoid articular surface heals
with smooth and concentric fibrocartilage [86].
One of the advantages of this technique is the preservation of the labrum during the
periglenoid capsular release that results with improved glenohumeral stability and concentri-
cally loading of the joint. If there is a need for a correction of glenoid version, this may also be
done by ream and run procedure. But if there is severe posterior wear, this condition may not
be appropriate for Ream and Run technique [87, 88].
Ream and run technique is suitable for primary glenohumeral arthritis patients who agree on
slow recovery to avoid glenoid loosening and medial erosion in the long-term. Even though,
the results were satisfying, due to the requirement of healing process in the glenoid for 12–18
months in non-RA patients, rheumatoid shoulders with destructive pattern are not seemed to
be suitable candidates, but this assumption was not proven according to our best of our
knowledge because the Ream and Run technique’s functional outcome has not been evaluated
on rheumatoid shoulders yet [87–91].
2.6. Anatomical total shoulder arthroplasty
Indications for TSA in rheumatoid shoulders are for the patients with intractable pain, end-
stage disease with extensive glenohumeral joint destruction, intact rotator cuff and yet with
sufficient bone stock and soft tissue balance to stabilize the prosthetic articulations (Figure 3)
[92]. The presence of mentioned factors makes the TSA superior treatment choice rather than
hemiarthroplasty. Because medial erosion of the glenoid which affects glenoid bone stock may
complicate the revision surgeries of hemiarthroplasty. Also the glenohumeral alignment can be
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achieved superiorly in TSA, especially in the patient group whose age is older than 50 which
was accepted as a predictor of pain relief and better functional outcome [92–94].
The assessment of rotator cuff status preoperatively is essential to avoid proximal migration
and consequently the rocking horse phenomenon. The survival of the glenoidal component
has a strong negative correlation with the fatty degeneration of the rotator cuff that can be seen
by ultrasonography and magnetic resonance imaging or decreased subacromial space seen in
the plain x-ray [33].
Neer’s nonconstrained TSA had achieved pain relief and low complication rates in rheumatoid
shoulders. But the poor bone stock, irreparable rotator cuff tears, soft tissue constraints dem-
onstrated an underestimated potential risk for arthroplasty [95–97]. Due to these factors of
rheumatoid shoulder, high rate of radiographic lucent lines, ranging from 30 to 93%which was
correlated with physical loosening of the components, created concerns about the long-term
survival of the TSA [95, 98]. Hambright’s study of perioperative status comparison between
rheumatoid and non-rheumatoid shoulders that had undergone TSA revealed no significant
difference among mortality and complications. Also, interestingly, even the hospital costs per
day were higher in rheumatoid shoulder patients; due to low hospital stay, overall in-hospital
costs were lower in comparison to non-rheumatoid patients. This fact was tried to be explained
by the RA patients’ experience of managing chronic disease and the pain [31, 99, 100].
Boileau et al. [101] and Martin et al. [102] studied the results of metal backed hydroxyapatite
covered uncemented glenoidal components for osteoarthritic patients with a follow-up of
3 and 7.5 years, respectively. Glenoidal component loosening was encountered in 20% of
Boileau et al.’s and 11% of Martin et al.’s patients, so considered as unfavorable and
uncemented glenoidal component was abandoned. Against these statements, Clement et al.
investigated the results of hydroxyapatite covered metal backed glenoid components in rheu-
matoid patients. A total of 36 shoulders were evaluated for 132 months and 1 out of 5
complication was seen as glenoidal loosening and survival of prosthesis in 10 years was found
Figure 3. Total shoulder arthroplasty surgery. (A) Preoperative AP plain radiography. (B) Preoperative axial CT scan. (C)
Postoperative 6th month AP plain radiography.
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for 89%. Their findings showed that the use of pegged which is more stable than keeled
component, thin metal back with thicker polyethylene because the polyethylene wear was
stated as the major factor for revision surgeries [103].
Also, Betts et al.’s study included 14 rheumatoid shoulders with a follow-up of 19.8 years. They
reported their functional outcomes, pain relief and complication rates. With the increase in
follow-up duration, radiolucencies around glenoidal and humeral component and rotator cuff
deficiency were progressed. But even with the presence of these radiological findings, functional
outcomes and satisfactory pain relief were especially achieved in elderly, non-demanding
patients. They managed their personal care and their sleep was undisturbed. Additionally, they
stated that proximal humeral migration was strongly relevant to glenoidal component loosening.
This phenomenon was explained by the rocking horse movements of the humeral component on
the glenoidal component which causes the eccentric loading on the glenoid component. The
exacerbating factors of the proximal migration were described as instability and rotator cuff
deficiency. Even the rotator cuff repair was performed; in the long-term, rotator cuff deficiency
was stated as inevitable [104].
In 1987, Kelly et al. reported their experience in Neer’s TSA in rheumatoid shoulders. After a
follow-up of 36 months; even the patients’ forward flexion (75) and abduction (68) were
moderate; because of the improvement in external (40) and internal rotation, patients managed
their daily living, thus the functional scores were satisfactory. But the main concern was the
glenoidal radiolucent lines that started to happen after 2 weeks of operation [105], but their
second updated publication in 1997 with a 9.5 year follow-up, revealed that even 23 of 37
glenoidal components had shown radiolucencies, only 24% were progressed and required fur-
ther evaluation for revision. The range of motion in the long-term was not significantly different
from their previous study [106].
Sneppen et al. published the long-term results of TSA in terms of complications in a rheuma-
toid patient group. Sixty-two shoulders were included and followed up for about 7 years. In
the total group, 54% of the patients showed proximal migration. Especially the patients with
preoperative Larsen grade V lesions had shown 69% proximal migration. But interestingly, the
occurrence of proximal migration did not influence the functional outcome of the patients.
About 89% of the patients achieved acceptable pain relief. Forward flexion and abduction were
significantly increased according to the preoperative state. They also stated that because of the
glenoid’s poor bone stock, the glenoidal component’s keel might be trimmed to achieve a
proper fitting. Thus, the use of metal back components might not be the suitable choice for
these patients. The authors also advised the use of cemented humeral component because even
the perioperative state of humerus was seemed to be in good shape, 5 out of 12 patients had
shown humeral component loosening in contrary of 50 patients with cemented humeral
component which had shown no sign of radiolucency [107]. In contrary, Trail et al. supported
the uncemented humeral component in their study (n = 144) because 13% of the patients had
shown the radiolucent lines around the humeral component but it was neither progressive nor
symptomatic [108]. Barlow et al.’s updated study about arthroplasty series in rheumatoid
shoulder included largest patient population in literature. A total of 195 anatomical total
shoulders and 108 hemiarthroplasty was included in study and followed up for 13.8 years.
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The radiographic evaluation of TSA revealed that 72% of the patients had radiolucent lines
around glenoid component, in contrast to hemiarthroplasty’s glenoid erosion which occurred
in 98% of the patients. Even the presence of radiolucency rates was higher for TSA, in the 10th
year of follow- up; TSA’s survival was 92.9% and with an intact rotator cuff survival was
increased to 96.7%. In contrary, hemiarthroplasty’s 10 year survival was 87.9% but with an
intact cuff survival was decreased to 75.8%. They stated that even the glenoidal component
loosening is a catastrophic complication; with the presence of an intact rotator cuff, the sur-
vival of the prosthesis is superior to hemiarthroplasty [109].
Glenoid loosening also depends on the morphology of the glenoid. Walch et al. identified five
types glenoid morphology (A1, A2, B1, B2, C) in 113 patients’ computed tomography scans.
A1, A2 and B1 represents a lesser risk for glenoid component insertion and long-term loosen-
ing in contrast to B2 and C type glenoids. Key feature of the morphology of B2, C glenoids is
the excessive retroversion [110]. Surgical techniques vary depending on the morphology but
all technique has its disadvantage. Anatomical glenoid correction by reaming may be
performed but as a result, the joint will be medialized, thus the lever arm of the surrounding
muscle will decrease [111]. Also due to excessive reaming, glenoid bone stock will be lost and
while inserting the component, the pegs may perforate the cortex which will result as loosen-
ing, fracture and in the long-term the revision surgery will be complicated. To protect the bone
stock, glenoid may be reamed retrovertly without correcting version, but this technique repre-
sents a threat for perforation of anterior cortex by the inserted pegs and also more than 10 of
retroversion increases the subluxation and instability of the prosthesis. To fill the defect of
eroded area by bone graft in the posterior glenoid is another choice, but cemented glenoid
components carry the risk of graft osteolysis. Metal backed hydroxyapatite covered compo-
nents may be chosen. The advancement of prosthesis technology created posterior augmented
glenoid designs. This component’s augment fits on the defected glenoid, thus the reaming of
anterior glenoid will be prevented [111, 112]. Kersten et al. compared the standard glenoid
component with wedge and stepped posterior augmented glenoid component. Posterior aug-
mented glenoid components confirmed that bone loss in glenoid is decreased significantly
according to standard type glenoid components. Also comparison of the subgroups of poste-
rior augmented components, the wedge-shaped required lesser reaming, thus bone stock
removal was lesser than the stepped glenoid component and as a result lower risk for glenoid
loosening might be achieved with wedged-shaped posterior augmented glenoid component
[111]. Also Greiner et al. investigated the radiolucent line occurrences according to morphol-
ogy. B2 and C glenoid types showed significantly higher radiolucent lines around glenoidal
component after a follow-up of approximately 5 years [112]. Although these studies were
performed on mostly primary osteoarthritis, surgical technique choices may give clues about
patient specific approach.
In conclusion, as the advancement in prosthesis and improvement in surgical techniques,
recent literature supports TSA for young- and old-aged patients with an intact or reparable
rotator cuff. Rotator cuff deficiency and poor glenoid bone stock are the main perioperative
challenges of TSA, but with the repair of rotator cuff and adjusting the glenoidal component by
trimming had shown statistically significant pain relief and also improved functional out-
comes. The identification of the glenoid morphology carries great importance to assess the
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surgical technique for overwhelming the most common complication of the TSA. In the long-
term follow-up, the radiolucencies around components had created concerns about loosening,
but the progression of radiolucencies is more trustworthy for this diagnosis [50]. Summary of
the literature for TSA can be found in Table 5.
2.7. Reverse shoulder arthroplasty
Although hemiarthroplasty and TSA had shown superiorities to each other in the absence of
rotator cuff, instability, superior migration, weakness of the arm and limited range of motion
created concerns [113–116]. Van de Salde et al. correlated the joint space obliteration with
rotator cuff fatty infiltration [117]. Grammont et al. in 1993 designed an anatomically inverse
implant. Humeral cup became concave and glenoid became convex. Thus, the rotator cuff’s
altering muscle vectors against the deltoid could be neglected and the implant would become
deltoid dependent. Also for its design joint movement center was medialized and located
inferiorly, thus increased the moment arm of the deltoid and eliminated the forces applying to
glenoidal component [118]. Because of the deltoid dependency, perioperative assessment of
deltoid tension after insertion of the implant carries great importance (Figure 4) [116].
Rittmeister et al. published their experience with RSA in 2001. Seven patients (eight shoulders)
were included and inclusion criteria was determined as joint pain, restricted joint movements
which deteriorates daily living, evaluation of irreparable rotator cuff and advanced destructive
pattern in radiological examination. Their mean follow-up duration was 54.3 months. Their
main concerns were the glenoidal component and cuff pathology. Because of the inclusion
criteria, advanced staged patients’ glenoidal bone stock was not ideal for the insertion of the
screws, thus loosening of the glenoidal component and perioperative glenoid fractures were
encountered. Additional concern in rheumatoid shoulder, teres minor, infraspinatus were
damaged in addition to supraspinatus, which created stability issues for the implant [116].
Another study by John et al. included 20 patients with 22 advanced staged rheumatoid
shoulders. The evaluation of the patients was made by patient orientated and a clinical
assessment with a mean follow-up of 24.3 months. They concluded that in patients with torn
rotator cuff and advanced radiological changes, RSA improved the quality of life. Only com-
plication mentioned was scapular notching which did not progress after 1 year of follow-up
and also did not significantly change the functional outcome of the patients [119].
In contrast, Tiusanen et al. included 76 RSA patients who needed to be revised after hemiarth-
roplasty failure. In their retrospective natured study, evaluations were made preoperatively and
1, 3, 6, 12, 36 months after surgery. They stated that even though the results were from a revised
patient group, their range of motions increased gradually till their postoperative first year, after
that a steady state was encountered. Patient satisfaction was achieved for 90% of the patients and
no major complications were seen [120].
Holcomb et al. presented a larger case series (21 patients) with a mean 36 months follow-up.
Included patients demonstrated heterogeneity for Larsen classification. For the Larsen Grade
IV and V patients, glenoid structural autografts were used which were acquired from humeral
head. The results revealed good functional outcomes and pain relief. Eight patient stated good
or excellent outcome. Against the statement of Rittmeister, they found fewer complications
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Publication N Age
(mean)
Follow-up PRE-op score Post-op score Improvement
in FF
Improvement
in ER
Satisfaction Complication Conclusion
Kelly et al.
(1987) [105]
41 57 (range
21–59)
36 months
(range 12–66)
Daily living
activities: 16 (score
value: min.9,
max.36)
Daily living
activities: 30 (score
value: min.9,
max.36)
20 29 %88 1 (postoperative pain
due to rotator cuff tear)
Non-constraint total shoulder
arthroplasty is a valuable
surgical option with excellent
pain relief and moderate
functional outcome which is
due to impaired rotator cuff
Friedman
et al. [97]
24 59 (range
32–79)
54 months
(range 24–
120)
Pain score: 1.1 (score
value: min:1, max:5)
Daily living activity:
1 (score value: min:
0, max:5)
Pain score: 4.3 (score
value: min:1, max:5)
Daily living activity:
3 (score value: min:
0, max:5)
38 11 %92 None With the restoration of
mechanical integrity; pain
relief, motion improvements
can be achievable with total
shoulder arthroplasty.
Sneppen
et al. [107]
62 57 (range:
31–75)
92 months
(range: 52–
139)
ASES: 15.02 ASES: 28 44 6 %89 1 (glenoid loosening) The presence of proximal
migration does not effect the
functional outcomes, but even
pain relief and motion
improvement can be achieved
with total shoulder
arthroplasty, glenoidal
loosening is a major concern
Stewart
et al. [106]
37 55 (range
22–71)
114 months
(range 84–
156)
N/A N/A 22 33 %89 6 (3 glenoidal
component loosening, 2
humeral component
loosening, 1 deep
infection)
Even the radiolucency rates
are high in operated
rheumatoid shoulders, not all
patients had shown loosening
and required revision.
Trail et al.
[108]
40 59.1  12.7 61 months
(range 25–
105.6)
Constant: 12.3
ASES: 22.3
Constant: 33.7
ASES: 56.9
17 20 N/A N/A Total shoulder arthroplasty
relieves pain, improves
strength and range of motion,
and also use of cemented
humeral stem and pegged
glenoidal component result in
good fixation
Betts et al.
[104]
14 47.7 (range
21–67)
231.6 months
(range 198–
285.6)
N/A N/A 15 20 N/A 5 (1 post-operative
rotator cuff tear, 1
infection, 1 aseptic
loosening of both
components, 2 reasons
unclear
Even though total shoulder
arthroplasty enables the daily
life activity, due to rotator cuff
deficiency in rheumatoid
shoulder, loosening rates are
increased.
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Publication N Age
(mean)
Follow-up PRE-op score Post-op score Improvement
in FF
Improvement
in ER
Satisfaction Complication Conclusion
Clement
et al. [103]
29 55 (range
35–86)
132 months
(range 96–
168)
Constant: 20.6 Constant: 33.5 4 10 N/A 5 (3 superior luxation of
humeral head, 1 for
infection, 1 for aseptic
loosening)
Hydroxyapatite covered metal
backed glenoid components
key features for survival are
the low profile metal back,
hydroxyapatite cover and
fixation of glenoid component
with screws
Abbreviations: ER, external rotation; FF, forward flexion; ASES, American Shoulder and Elbow Surgeons Score.
Table 5. Summary of previous publications about total shoulder arthroplasty in RA patients.
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and only three required revision surgery. Two of these three were evaluated as periprosthetic
infection which occurred after 7 weeks and 6 years after surgery. They explained their low
infection rates to routinely used tobramycin added methylmethacrylate. They supported that
even though all rotator cuff muscles are affected by fatty infiltration, the choice of RSA is
reasonable with improved functional outcomes, pain relief and low complication rates [121].
Guery et al. in 2006 published a survival analysis for RSA. They advocated that because of high
infection rate and low quality of glenoid bone stock in RA, the use of RSA was contraindicated
[122]. But after 5 years, Young et al. in the same institute published their experience of RSA in
RA with an intermediate follow-up (3.8 years). No complications were seen that needs to be
intervened by surgery. The structural bone graft acquired from resected humeral head is
enough for restoring glenoidal bone stock and healing of the graft was satisfactory. As for the
Figure 4. Reverse shoulder arthroplasty surgery. (A) Preoperative AP plain radiography. (B) Preoperative coronal CT
scan. (C) Early postoperative plain radiography. (D) Postoperative 6th month plain radiography.
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Publication N Age (Mean) Follow-up Pre-op
Score
Post-op
Score
Improvement
in FF
Improvement
in ER
Satisfaction Complications Conclusion
Rittmeister
et al. [116]
8 60.25 (range 34–86) 54.3 months
(range 48–
73)
Constant:
17
Constant:
63
N/A N/A 100% 3
(reosteosynthesis
of acromion
required)
Reverse shoulder
arthroplasty provides a
stable and functional
joint even though the
deltoid is the functioning
sole muscle when the
rotator cuff is beyond
restoration
Holcomb
et al. [121]
21 70.3 (range 53–86) 36 months
(range 24–
73)
ASES: 28
SST: 1
VAS
function
score:: 3
ASES: 82
SST: 7
VAS
function
score: 6
74 14 99.6% 3 (2 infection, 1
periprosthetic
fracture)
Reverse shoulder
arthroplasty is a reliable
treatment option for
rotator cuff deficient
rheumatoid shoulders in
contrary to previous
reports, but long-term
results are needed.
Young et al.
[123]
16 70.1 (range 46.3–
83.6)
45.6 months
(range 25–
84)
Constant:
22.5
Constant:
64.9
61.6 29.2 94% None Reverse shoulder
arthroplasty results in
rheumatoid shoulder are
promising but care must
be taken against intra
and postoperative
fractures in this
population
Tiusanen
et al. [120]
76 70.7 (range 49–90) 36 months N/A N/A 48.5 5.5 90% 25 scapular
notching (Grade
I:19,
Grade II: 3,
Grade III: 3)
Even though external
and internal rotations are
limited, with no major
complication, and
improved FF, extension;
high patient satisfaction
can be achieved.
Abbreviations: ER, external rotation; FF, forward flexion; ASES, American Shoulder and Elbow Surgeons Score; SST, Simple Shoulder Test; VAS, Visual Analogue Scale.
Table 6. Summary of previous publications about reverse shoulder Arthroplasty in RA patients.
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functional outcome, the forward flexion was increased to 138.6 which was a good functional
outcome according to the total shoulder and hemiarthroplasty patients with the same radio-
graphic properties. Eleven patients were stated as good or excellent result. But for the external
rotation, the increase was not statistically significant. With an intact teres minor, external
rotation was improved significantly when the arm was abducted 90 [123].
Even Holcomb et al. [121] stated their infection rate for 9.5% in 21 patients, Young et al. [123]
stated 0% infection rate after RSA in rheumatoid shoulder. But a larger case series was
published by Morris et al. with 42 rheumatoid shoulders contributing in 301 RSA. Only 5% of
patients with RA were infected and required revision. They concluded that RA was not a bad
prognostic factor for periprosthetic infection after RSA application [124].
In 2016, Liu et al. evaluated the osteoarthritic patients’ return to sports after RSA or hemiarth-
roplasty surgeries. Even though minor population represents the RA patients, it may give some
clue for the functionality of RSA. Inclusion criteria were the patients who had a contraindication
for TSA and RSA or hemiarthroplasty was decided. A total of 102 RSA and 71 hemiarthroplasty
patients were evaluated for 31.7 and 62.9 months, respectively. They concluded that RSA had a
better return to sports activities than hemiarthroplasty, especially when the patient was female,
younger than 70 of age and had a rotator cuff deficiency [125].
In conclusion, the choice for RSA is reserved for old aged, irreparable rotator cuff deficient
patients. According to larger case series, the patients with morning stiffness, advanced radiolog-
ical destruction of glenohumeral joint is considered to be the indication for RSA. The challenges
for low glenoidal bone stock can be overwhelmed with the use of autografts acquired from
humeral head to reinforce the glenoidal bone stock [50]. In the light of recent literature, we can
assume that RSAwill play role in young-aged patients due to return to sports rate and improved
functional status. The functional status and complications of previous literature about RSA are
summarized in Table 6.
3. Conclusion
We tried to simplify the indications, advantages and disadvantages above-mentioned treat-
ment options in Table 7 and Figure 5. Main critical factors for decision making for optimal
surgical treatment are patients’ age, functional demand, rotator cuff status and remaining
glenoid bone stock. Treatment for young-aged patients will require a long-term survival rated
surgical treatments or a short-term treatment with preservation of bone stock to revise to
prosthesis. If the patients’ radiological evaluation is below Larsen class II, synovectomy or
bursectomy may be preferred, but if it is moderately or severely deformed, rotator cuff status
becomes the main identifier. If rotator cuff is intact, surgeon can prefer hemiarthroplasty or
resurfacing arthroplasty which preserves glenoidal bone stock and with good survival rate.
With torn rotator cuff, the situation becomes more dire, even though good functional outcomes
can be achieved with anatomic TSA and rotator cuff repair, in long-term follow-up rotator cuff
degeneration is inevitable which results in pain because of superior migration of prosthesis
and loss of glenoidal bone stock, also tragically glenoidal component loosening due to rocking
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Procedure Pain relief Advantages Disadvantages Purpose Rotator cuff
dependency
Glenoidal bone
stock
requirement
Synovectomy and
bursectomy
Yes • Easy to Perform • Unable to prevent disease
progression in the joint
• Only early stage patients
can be candidates
Symptomatic relief No No
Resection
interposition
arthroplasty
Controversial • Slows the progression of
destruction
• Protects bone stock
• Delays arthroplasty
requirement
• Limited range of motion
• Humeral head resorption
Convertible arthroplasty
choice for the young aged
Yes No
Resurfacing
arthroplasty
Yes • Protects bone stock
• High satisfaction rates
• Lower glenoid erosion
rate than HA
• Superior migration
• High radiological
loosening
Protects bone stock with
good functional results and
enables future revision
options
Yes (with intact RC,
lower rate of
complication)
No
Hemiarthroplasty Yes • Stable glenohumeral joint
• Convertible to TSA
• Good functional outcome
• Low loosening rates
• Painful glenoid erosion
• Decreased satisfaction
rates after 10 years
Pain relief without losing
glenoid bone stock
No (with intact RC,
better functional
outcomes)
No
Total shoulder
arthroplasty
Yes • Stable glenohumeral joint
• Better functional outcome
than HA
• Prevents the progression
of destruction
• Decreased functional
outcome after deterioration
of RC
• Concern of glenoidal
loosening
To achieve better
glenohumeral joint
alignment and functional
outcome
Yes Yes
Reverse shoulder
arthroplasty
Yes • Good functional outcomes
even after RC tear occurs
• High satisfaction rates
• Complicated revision
surgery
• No alternative
arthroplasty
To achieve good functional
outcomes even after RC
tear occurs
No Yes
Abbreviations: HA, hemiarthroplasty; TSA, anatomical total shoulder arthroplasty; RC, rotator cuff.
Table 7. Brief comparison of treatment modalities in rheumatoid arthritic shoulder.
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horse phenomenon. RSA can be an option but literature lacks young-aged patients’ outcomes.
Recently, researches about RSA are focused on the daily functioning of patients and the results
are promising. It can be foreseen that RSA age limit will be lowered in the future. In old-aged
(>50 years) patients’ radiological evaluation is mostly advanced to Larson class III. Main
indicators are still rotator cuff and glenoidal bone stock for decision making. If the rotator cuff
is intact and adequate glenoidal bone stock is present, TSA will be the optimal choice with
long-term survival and good functional outcome. But if the glenoid bone stock is inadequate,
hemiarthroplasty may be the optimal choice, also TSA with autograft use from humeral head
would promise a better functional demand in these groups of patients. With the degeneration
of the rotator cuff, surgical options narrow down to hemiarthroplasty and RSA. If glenoidal
bone stock is adequate RSA would be optimal, but with inadequate glenoid bone stock, hemi-
arthroplasty still provides good functional demand but not better than autograft supported
RSA. Even though these treatment indications are disputed, they will provide useful informa-
tion for the surgeon dealing with RA.
The decision making of a RA patient with shoulder pain is still a challenging concept. Not
because of the mentioned criteria but also for the disease nature, lower extremity concerns
which might have led the patient to use upper extremity for mobilization by an apparatus.
Figure 5. A treatment strategy for the surgical treatment of rheumatoid shoulder [50].
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Thus the shoulder surgery might cause an immobilization and further decrease the quality of
life for the patient. Consultation and working together with a rheumatologist for following-up
is essential for the patient’s health status because of cessation of RA drugs preoperatively and
following-up postoperatively. Decision making process must be made according to other
concerns and needs of the patient and discussed thoroughly with the patient and also his/her
rheumatologist.
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